Press release Biocartis Group NV: Biocartis en SkylineDx tekenen samenwerking voor ontwikkeling van Merlin Assay, een test die risico voorspelt voor nodale metastasen in melanoom, op Idylla™

Bud Bilanich
Success Coach

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing

Matt Turner
Patient Affordability

Pat Purcell
Meeting Engagement

Stacey Gandler
Brand Nourishment

Joey Cohen
Medication Adherence

Brenda Snow
Authentic Patient Voice

Suma Ramadas, PhD
Medical Affairs

Daniel Sontupe
Market Access

David Linetsky
Point-of-Care Marketing

Liz Kane
Impactful Strategy

Paul Theisen
Patient Acquisition

Amy Giles
Increasing Engagement